Jin-Hee Ahn


Ontology type: schema:Person     


Person Info

NAME

Jin-Hee

SURNAME

Ahn

Publications in SciGraph latest 50 shown

  • 2022-05-12 Association between tumor 18F-fluorodeoxyglucose metabolism and survival in women with estrogen receptor-positive, HER2-negative breast cancer in SCIENTIFIC REPORTS
  • 2022-03-12 Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastoma in CELLULAR AND MOLECULAR LIFE SCIENCES
  • 2021-07-13 Does merged three-dimensional mapping improve contact force and long-term procedure outcome in atrial fibrillation ablation? (MICRO-AF study): a prospective randomized controlled study in THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
  • 2021-06-03 Targeted mutagenesis in mouse cells and embryos using an enhanced prime editor in GENOME BIOLOGY
  • 2021-05-18 Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer in SCIENTIFIC REPORTS
  • 2021-02-09 Usefulness of 3D-surgical guides in breast conserving surgery after neoadjuvant treatment in SCIENTIFIC REPORTS
  • 2021-01-08 An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer in NATURE COMMUNICATIONS
  • 2020-11-28 Histopathologic response after hydrophilic polyethylene glycol-coating stent and hydrophobic octadecylthiol-coating stent implantations in porcine coronary restenosis model in JOURNAL OF MATERIALS SCIENCE: MATERIALS IN MEDICINE
  • 2020-10-06 Cardiogenic vertigo: characteristics and proposed diagnostic criteria in JOURNAL OF NEUROLOGY
  • 2020-10-05 Association of left atrial pressure with late gadolinium enhancement extent in patient who underwent catheter ablation for atrial fibrillation in SCIENTIFIC REPORTS
  • 2020-08-11 TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation in NATURE COMMUNICATIONS
  • 2020-06-30 Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study in TARGETED ONCOLOGY
  • 2019-11-06 Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16) in BRITISH JOURNAL OF CANCER
  • 2019-09-20 Dopamine neuron induction and the neuroprotective effects of thyroid hormone derivatives in SCIENTIFIC REPORTS
  • 2019-07-30 Characteristics of metastatic brachial plexopathy in patients with breast cancer in SUPPORTIVE CARE IN CANCER
  • 2019-07-04 The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma in RADIATION ONCOLOGY
  • 2019-05-01 Synthesis and in vivo characterization of 18F-labeled difluoroboron-curcumin derivative for β-amyloid plaque imaging in SCIENTIFIC REPORTS
  • 2019-04-11 Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2019-02-28 How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers in JOURNAL OF CANCER EDUCATION
  • 2019-01-24 ENOblock inhibits the pathology of diet-induced obesity in SCIENTIFIC REPORTS
  • 2018-07-26 Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers in NPJ BREAST CANCER
  • 2018-05-30 Long-term clinical outcomes of catheter ablation in patients with atrial fibrillation predisposing to tachycardia-bradycardia syndrome: a long pause predicts implantation of a permanent pacemaker in BMC CARDIOVASCULAR DISORDERS
  • 2018-04-12 A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes in NATURE COMMUNICATIONS
  • 2016-08-04 Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016-04-29 Small molecules that allosterically inhibit p21-activated kinase activity by binding to the regulatory p21-binding domain in EXPERIMENTAL & MOLECULAR MEDICINE
  • 2016-01-18 Pharmacokinetic characterization of 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone, a novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor in rats in ARCHIVES OF PHARMACAL RESEARCH
  • 2015-12-21 Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2015-11-03 Prognostic tissue biomarker exploration for patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors in TUMOR BIOLOGY
  • 2015-10-22 Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR in BMC CANCER
  • 2015-10-07 High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers in VIRCHOWS ARCHIV
  • 2015-05-26 Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-03-17 Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2015-03-01 Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer in TUMOR BIOLOGY
  • 2014-12-10 Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer in BMC CANCER
  • 2014-11-27 Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10–17) in BRITISH JOURNAL OF CANCER
  • 2014-09-06 Correlations Between Molecular Subtypes and Pathologic Response Patterns of Breast Cancers After Neoadjuvant Chemotherapy in ANNALS OF SURGICAL ONCOLOGY
  • 2014-07-02 Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting in TUMOR BIOLOGY
  • 2014-05-13 Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-04-22 Active surveillance for metastatic or recurrent renal cell carcinoma in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2014-04-15 Gemcitabine–oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed in BRITISH JOURNAL OF CANCER
  • 2014-04-09 Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial in INVESTIGATIONAL NEW DRUGS
  • 2014-03-27 Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-01-03 Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets in ANNALS OF SURGICAL ONCOLOGY
  • 2013-09-14 Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide in INVESTIGATIONAL NEW DRUGS
  • 2013-08-10 Erratum to: Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2013-07-11 Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-05-14 Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-02-09 Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2012-12-17 Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients in HEALTH AND QUALITY OF LIFE OUTCOMES
  • 2012-09-18 A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by [18F]fluorothymidine-positron emission tomography in INVESTIGATIONAL NEW DRUGS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.413967.e", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.262229.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412588.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411158.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.222754.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412786.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.263736.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417993.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.29869.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.47840.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416846.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418549.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.249967.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414964.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.264381.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411728.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.61221.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267370.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411134.2", 
            "type": "Organization"
          }
        ], 
        "familyName": "Ahn", 
        "givenName": "Jin-Hee", 
        "id": "sg:person.01046307125.06", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-6957-6062"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046307125.06", 
          "https://orcid.org/0000-0002-6957-6062"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-08-04T17:38", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/person/person_703.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01046307125.06'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01046307125.06'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01046307125.06'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01046307125.06'


     

    This table displays all metadata directly associated to this object as RDF triples.

    57 TRIPLES      11 PREDICATES      31 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01046307125.06 schema:affiliation Na2fc496a776145bcbb98128fe379996e
    2 grid-institutes:grid.222754.4
    3 grid-institutes:grid.249967.7
    4 grid-institutes:grid.262229.f
    5 grid-institutes:grid.263736.5
    6 grid-institutes:grid.264381.a
    7 grid-institutes:grid.267370.7
    8 grid-institutes:grid.29869.3c
    9 grid-institutes:grid.411134.2
    10 grid-institutes:grid.411158.8
    11 grid-institutes:grid.411728.9
    12 grid-institutes:grid.412588.2
    13 grid-institutes:grid.412786.e
    14 grid-institutes:grid.414964.a
    15 grid-institutes:grid.416846.9
    16 grid-institutes:grid.417993.1
    17 grid-institutes:grid.418549.5
    18 grid-institutes:grid.47840.3f
    19 grid-institutes:grid.61221.36
    20 schema:familyName Ahn
    21 schema:givenName Jin-Hee
    22 schema:identifier N2808e37988c442a6a829daec23ee55f1
    23 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046307125.06
    24 https://orcid.org/0000-0002-6957-6062
    25 schema:sdDatePublished 2022-08-04T17:38
    26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    27 schema:sdPublisher N8d7188f2e0cc451c8a5b55c5d066ede3
    28 sgo:license sg:explorer/license/
    29 sgo:sdDataset persons
    30 rdf:type schema:Person
    31 N2808e37988c442a6a829daec23ee55f1 schema:name orcid_id
    32 schema:value 0000-0002-6957-6062
    33 rdf:type schema:PropertyValue
    34 N8d7188f2e0cc451c8a5b55c5d066ede3 schema:name Springer Nature - SN SciGraph project
    35 rdf:type schema:Organization
    36 Na2fc496a776145bcbb98128fe379996e schema:affiliation grid-institutes:grid.413967.e
    37 sgo:isCurrent true
    38 rdf:type schema:OrganizationRole
    39 grid-institutes:grid.222754.4 schema:Organization
    40 grid-institutes:grid.249967.7 schema:Organization
    41 grid-institutes:grid.262229.f schema:Organization
    42 grid-institutes:grid.263736.5 schema:Organization
    43 grid-institutes:grid.264381.a schema:Organization
    44 grid-institutes:grid.267370.7 schema:Organization
    45 grid-institutes:grid.29869.3c schema:Organization
    46 grid-institutes:grid.411134.2 schema:Organization
    47 grid-institutes:grid.411158.8 schema:Organization
    48 grid-institutes:grid.411728.9 schema:Organization
    49 grid-institutes:grid.412588.2 schema:Organization
    50 grid-institutes:grid.412786.e schema:Organization
    51 grid-institutes:grid.413967.e schema:Organization
    52 grid-institutes:grid.414964.a schema:Organization
    53 grid-institutes:grid.416846.9 schema:Organization
    54 grid-institutes:grid.417993.1 schema:Organization
    55 grid-institutes:grid.418549.5 schema:Organization
    56 grid-institutes:grid.47840.3f schema:Organization
    57 grid-institutes:grid.61221.36 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...